Qiming readies to kick off Chinese New Year with a first for Hong Kong exchange

After Qiming closed its sixth RMB fund in late January, Managing Partner Nisa Leung is looking ahead to her firm’s second public listing this year, one that she believes could clear a path for more diagnostics companies to go public via the Hong Kong stock exchange’s biotech chapter.

New Horizon Health Ltd. is slated to become the first diagnostics company on the exchange’s Chapter 18A — which debuted nearly three years ago to  fill a much-needed void in the region for prerevenue companies — when it goes public after Chinese New Year. ...